Illinois Archives - Green Market Report

Sean HockingSean HockingAugust 20, 2019
Illinois-1280x1275.jpg

9min1381
If you wish to re-publish this story please do so with the following accreditation
AUTHOR:  “Jordan Zoot.  “aBIZinaBOX Inc., CPA’s
PUBLISHER:  CANNABIS LAW REPORT

IDPH Making Effort – we are somewhat pleasantly SHOCKED and SURPRISED that the Illinois Dept. of Public Health in particular, and State of Illinois government, in general, seems to be making a REAL and CONCERTED effort to implement cannabis policy.

A bit of background is in order – I am personally licensed as a CPA in California, Florida, Illinois, New York, and Texas. The firm is licensed in California, Florida, Illinois and Oregon [due to quirks of CPA licensing at the firm and individual levels and types of practice services performed. I spent the first nineteen years of my career located in New York City, the next eighteen in Chicago, and have had an increasing presence in Oakland over the past three years. Our cannabis industry involvement since roughly 2001 has been entirely in California due to our perception that Illinois state government was corrupt as hell…and that even extended to my home town off Evanston [See outrageous lease ordinance for cannabis dispensary implemented by Evanston City Council when Illinois first legalized MMJ at ) Ordinance 40-O-15 Authorizing City Manager to Execute a Lease Agreement for City-Owned Property at 1804 Maple Avenue and Illinois Cannabis Corruption and Secrecy ] A US District Court Judge forced Illinois to add intractable pain to the MMJ statutes qualifying condition in January 2018 [See Article here.] We have addressed the outrageous terms of that lease elsewhere.

 

IDPH Making Effort To Get It Right

Keep in mind that the State of Illinois legalized medical cannabis [“MMJ”], in August 2013 [Illinois Governor Patrick Quinn signed Public Act 098-0122 “The Compassionate Use of Medical Cannabis Pilot Program Act” into law with an effective date of January 1, 2014 (the “Medical Cannabis Act”)].

The Illinois Legislature passed legislation on June 4, 2018, which would allow potentially thousands of patients to receive medical marijuana as an alternative to highly addictive opioids, a move that could provide a notable boost to MMJ sales. The state’s Governor signed the legislation in August 2018. The legislation allowed the use of medical cannabis as an alternative to opioids – a development that could eventually generate hundreds of millions of dollars in additional MMJ sales. Marijuana Business Daily estimates the move could add tens of thousands of new patients to a program that has roughly 42,000 currently registered.

Illinois had been a highly restrictive MMJ market. But the Marijuana Policy Project noted some key provisions of the legislation that will ease restrictions, including:

Qualifying patients will receive provisional registration allowing them to purchase medical marijuana for 90 days while their application is being processed (or until it is denied).

Criminal background checks and fingerprint requirements will be eliminated for all participants/applicants in the existing MMJ program and the new Opioid Alternative Pilot Program.

 

IDPH Making Effort To Get It Right

Illinois became the country’s first state to legalize recreational marijuana cultivation and sales through its Legislature, a landmark move that paves the way for the creation of one of the nation’s largest adult-use cannabis markets offering “huge” business opportunities on May 31, 2019 [See Illinois Adult Use and Illinois Cannabis Priorities  , and Illinois House Bill 1438.]

It seems that after the difficult climb to legalize adult-use Illinois has started to get its act together. Illinois Governor J.B. Pritzker signed new legislation on

MMJ qualifying conditions added are chronic pain, anorexia nervosa, irritable bowel syndrome, migraines, osteoarthritis, anorexia nervosa, Ehlers-Danlos syndrome, Neuro-Behcet’s autoimmune disease, neuropathy, polycystic kidney disease and superior canal dehiscence syndrome. Chronic pain tends to be the leading driver for MMJ sales.

Nurse practitioners and physician’s assistants, like doctors, now can certify patients for the program. [This is groundbreaking for MMJ programs]

The expansion gives added heft to a program that was bolstered substantially in late January when an opioid alternative pilot program kicked in. Former Republican Gov. Bruce Rauner signed that legislation.

 

IDPH Making Effort To Get It Right

We note that the enactment of adult-use legislation usually results in a decline in MMJ use of cannabis. However, Illinois has done something very encouraging in this regard.

The state’s MMJ program is that there is only a 1% sales tax.

Buyers of adult-use cannabis products, on the other hand, can expect to pay a retail tax of 19.55%-34.75%, depending on the product’s potency, according to the Marijuana Policy Project.

The Marijuana Business Factbook recently projected that the Illinois MMJ market would generate $200 million-$240 million in sales in 2019, up from $132.9 million in 2018.

While we have been reluctant to involve our practice in the Illinois cannabis market for close to twenty years, we may test the water. The first major step in this direction is that I have personally applied for an Illinois MMJ card due to my continuing struggle with diabetic neuropathy in my feet. The background to my healthcare team includes my Endocrinologist and Neuromuscular Neurologist at Northwestern Memorial, and Wound Care/ and Pain Management at Shirley Ryan Ability Labf/k/a Rehabilitation Institute of Chicago [“RIC”].

 

IDPH Making Effort To Get It Right

We are going to try both topical CBD for day time use and a high-concentration THC product for night-time pain use. The current Illinois MMJ program Dehabilitating Conditions list is here. The website for the IDPH Opioid Alternative Pilot Program is here. The overall growth of the Illinois MMJ program can be tracked here. The main website for the Illinois MMJ Cannabis Program.

If you are a licensee or are seriously considering applying for a license for a “plant-touching” cannabis business in Illinois preferably in Cook, Lake or McHenry County, we would REALLY like to hear from you. We have very deep and extensive experience with the legal cannabis industry on the Federal level, with extensive experience in California, and significant experience in Oregon. We would be willing to substantially discount our fees and dive into the Illinois cannabis market if we had a significant client. Our further preference is for an operator that is either substantially capitalized or venture-funded with a minimum of $2MM capitalization. Our experience is that we are overpowered for a “mom and pop” and most “friends and family” operations. If you have the interest, enter your contact information below.

 


Video StaffVideo StaffMay 15, 2019

75min7600

This panel was recorded on May 7 at the Green Market Summit in Chicago.

Kris Krane, 4Front Ventures:                         So this panels about the economics of cannabis in Illinois. I’m sure a lot of people are very interested in the bill that was just introduced. So we’re going to get to that later because I want you guys to stick around for the whole panel. We’ve got a medical marijuana program here, it’s still a pilot program, technically. Been fairly slow to develop compared to some other states. Can the panelists talk a little bit about what this program has looked like to date?

Ally Marotti, Chicago Tribune:                       So just to kind of give a snapshot of the numbers, we’re at about 62,000 patients right now. That has gone up, even in the past two or three months since February when the state rolled out their new opioid pilot program. Which allows anyone that is prescribing opioid to access medical cannabis.

The other big things that they did back in February, were that they eliminated the background check, and fingerprint requirements for patients, which made things a lot easier and quicker for patients to get their medical cards. They’ve also started granting provisional cards, which if you apply, you can get your card immediately and download it sort of like you would a plane ticket on your phone, and get into a dispensary that way. Instead of waiting, what was taking up to three months for the state to process your application.

So all over the state the numbers are up as far as foot traffic into the dispensaries, and I think we’ll see that. The main numbers haven’t been released yet, they usually release them at the beginning of the month. So I think we’ll see that going up kind of exponentially.

Larry Mishkin, Hoban Law:                    You know, the market in Illinois, for the medical side, has made great strides. It started out, I think, with a very rough roll out, and some uncertainty as we were changing governors right at that particular point in time. I don’t think it’s any shock or secret to say that our prior governor was no fan of this industry, probably … not probably, did a very good job of standing in the way of really giving the program a chance to grow, I think in the way that most people anticipated that it would grow. The hope is now that Governor Pritzker’s in charge, that he’s going to kind of take the shackles off of that a little bit, and really let the medical program go where it needs to go.

But we should all bear in mind that under the current law, the program has just about a year left, July of 2020, if the Illinois state legislature doesn’t expand the medical program, or make it permanent. That shouldn’t be lost in all the shuffle and excitement about adult use.

David Friedman, Young America Capital:               I think one of the positive things that’s come out of being, in what I think we would all agree was the most restrictive marketplace in the United States when the program first rolled out. I think the initial conditions were like nine-

Kris Krane:                          Jersey may have been a little more restrictive.

David Friedman:               Maybe. But if you look at the landscape of the companies that have come out of Illinois, there’s arguably four or five of the top ten MSO’s that have come out of Illinois. You’ve got the GTI’s, you’ve got the Cresco’s. I think by being in a highly regulated, restrictive environment, it forced some really significant capital to come into the space, and best practices to come out of the space. Illinois has actually become a leader in the international marketplace as a result of that early kind of restraints that were put on us.

Kris Krane:                          You know what’s fascinating me? You have really probably four or five of the, I would say, top 12 MSO’s in the country that are headquartered here in Chicago, that came out of this market, which is interesting given that it’s by and large been a pretty crappy market. Right? It’s on the face of it where you would think investors would be pouring lots of money right into the Illinois market when you’ve got a pilot program, you’ve got a really restrictive list of qualifying conditions. Everybody knew from day one this was not going to be the best sort of commercial market, and yet you do have some of these largest players in the country that came out of here.

David, you mentioned some of those reasons. I’d be curious to hear a little more from the panel why has Illinois, and Chicago in particular become such a hotbed for national companies given the relative weaknesses of the program?

Bill Marcus:                        I’ll comment on that. I can’t underscore. I cannot underscore David’s point enough that we happen to be one of the most restrictive, most difficult states to open up in. The capital, I was involved in looking at these companies as they rolled out, the intensive capital investment for a single facility license is upwards of $10 million to $15 million as a minimum, per license. And you have 15 operators here in Illinois-

Kris Krane:                          On the grow side.

Bill Marcus:                        Right, on the grow side. And on that grow side, I believe in the first year you had 7,000 to 10,000 patients.

David Friedman:               The first two years.

Bill Marcus:                        Yeah, you can’t imagine the kind of financial stress these companies went under. I know this because they had to go after round, after round. So to your point, I think it came out of the fact that we were lucky, and blessed that we had very strong capital markets and hedge funds centered in Chicago, that understood this, and were well schooled in terms of going the distance in these investments. They approached it not as a gamble, and not as a lark, it was very well thought out of, and very well supported from an investor base.

Larry Mishkin:                    I would agree with that, and I think that a lot of these guys from day one knew what they were going to do, or had very good ideas. The fact that Illinois was so restrictive, gave them great incentive to look outside of the state of Illinois, and to look at other states. But they’re all highly, highly qualified people who are all successful in other businesses. In that respect, it’s not really surprising at all.

Ally Marotti:                       Yeah, that’s a really good point. I think a lot of people … in other states out west, for example, the industry was built on the backs of folks that maybe were growing illegally, had been dabbling in it in some other way. But here it wasn’t like that. You had lawyers leaving their jobs. You had real estate executives leaving their jobs.

I think part of that is because it was so restrictive, the law was so complicated, you needed a lawyer to be behind a company, to get it up and running, and understand what all the restrictions were. But I think it’s been really interesting for me covering this industry. Up until really last summer, I think the biggest narrative was how all of these companies here were getting creative to find capital. Were they going to go public in Canada? Were they going to somehow convince an investor to invest in them? Were they going to move to another state and operate, which obviously is a big challenge to overcome in and of itself, but it does open up more capital in that way.

Again, as recent as last summer, there were a lot of companies here that had not recouped their investments from 2014-

Kris Krane:                          And still haven’t.

Ally Marotti:                       Still, yeah, exactly, exactly.

Kris Krane:                          We’re talking about increased patient numbers, we’re at 60,000 patients or so now. In a state of 13 million people, that’s not a lot.

Ally Marotti:                       Usually it’s 2% to 3%.

Kris Krane:                          That’s right.

Ally Marotti:                       And here, besides the opioid provision that I mentioned earlier, it’s still at about 40 conditions. Chronic pain is not one of them, that’s the biggest qualifying condition in most states.

Kris Krane:                          Let’s talk about that. As we’re talking about the development of the program to date, this has been not only discussed, but actually litigated, this issue of adding chronic pain and some others. Talk a little bit about what’s happened to date, or the efforts to date to get more qualifying conditions added, and where does that currently stand?

Larry Mishkin:                    Well, sure. We did not have a lot of success following the rules. The rules required submitting petitions to the governor’s board made up of 12 people who would meet every six months, and they would decide. Twice the governor’s board came back to the Department of Health with 12 conditions that they had all approved unanimously, and both times they were told, “No thank you,” and they were turned away.

Kris Krane:                          So the governor rejected his own panel’s recommendations?

Larry Mishkin:                    The governor rejected his own-

Kris Krane:                          He’s allowed to do that?

Larry Mishkin:                    He was allowed to do that under the law, yes.

Kris Krane:                          So what happens from there?

Larry Mishkin:                    Well, so what happens from there is we wind up with people filing lawsuits. Actually it’s been fascinating though, the lawsuit that filed for retractable pain, the theory was one of equal protection. That the state cannot, on the one hand, declare that cannabis is a medicine, but then on the other hand determine that it can be a medicine for some conditions, but not for other conditions. In what seemed like a very random way that they did it, and the state lost in the trial court. And the trial judge ordered the state to start admitting patients into the program with chronic pain.

Immediately Governor Rauner’s administration took the matter up on appeal, and as a result, the status quo was maintained, pending the ruling on the appeal. But it’s still on appeal. Governor Pritzker could direct Kwame Raoul, the State Attorney General, tomorrow to go in and withdraw the state’s objection. That would in effect immediately add chronic pain to the list of conditions that would allow you in.

Bill Marcus:                        Just to be clear, it’s not chronic pain, is it? It’s post-surgical intractable pain.

Larry Mishkin:                    Intractable pain, yeah.

Bill Marcus:                        It’s slightly different-

Larry Mishkin:                    Yes.

Bill Marcus:                        … it’s still wide open, but not quite as wide open as chronic pain.

Larry Mishkin:                    You’re right.

Kris Krane:                          And that hasn’t happened. The Governor’s not taken that step yet, and there’s a lot of people questioning why. The Governor campaigned on expanding the medical program, and on legalizing. The easiest thing that the Governor could do to expand the medical program is say, “Drop this appeal,” and all of a sudden you’ve gotten intractable pain, and a number of other conditions that will qualify. Why do folks think that hasn’t happened yet?

Larry Mishkin:                    I think that takes away some of his political power, to be able to push through the adult use. If all of a sudden you’re able to open the market widely to chronic pain, or intractable pain, then there’s less of an argument, and you could split the … even the majority or the super majority of democrats even more. They can say, “Well, we can kick adult use down the road.” So Pritzker’s a business man, right? If I’m him, I’m going to push through that legislation, and then I’ll circle back, and remove the blocks to the medical conditions.

Kris Krane:                          Do you think he’s waiting to see if the bill doesn’t pass?

Larry Mishkin:                    Maybe.

Ally Marotti:                       Yeah, I think we should also say too that there is a bill that’s been introduced that would make the medical program permanent. Because right now, I think you said that-

Kris Krane:                          Morgan’s bill.

Ally Marotti:                       Yeah, it’s still a pilot program in Illinois.

Kris Krane:                          Yeah, it expires next summer. We’ve got about 16 months or so left, I believe, until the program is technically expired, maybe less.

Larry Mishkin:                    Next year.

Kris Krane:                          Yeah, so less. Let’s stay on this issue, the qualifying conditions, because that really is what drives the market. We look at a state like a state like Arizona’s got about, I think, just over 5 million people, maybe 6 million people. There’s, I think, over 200,000 patients there now. And we’re still at 60,000 in a state of 13 million people here in Illinois. So it’s a pretty poor patient count, compared to what you see in a lot of more mature medical markets.

Ally, you mentioned the opiate bill, and that bill was meant to expand the patient population. I think we’ve seen that it has had an effect. It hasn’t quite had the effect, it seems, that folks may have expected though. So what have we seen out of the opiate bill?

Ally Marotti:                       So I think from what I’m hearing from operators, the biggest influx of patients right … in early February, right after they passed that bill, was from the folks that were granted provisional access. Like I talked about earlier, they could get in quick, they didn’t have to wait for the application to be processed.

We’ve been seeing the opioid has been making a difference. They’re reporting numbers on that separately from the medical cannabis program, because it’s seen as two different things. In April, there were about 1,000 patients enrolled in that. So pretty low numbers, I think for now. All the operators are expecting that to really pick up. In other states, I had mentioned, with chronic pain, which is different than allowing opioid patients. But you do get some of that population, 2% to 3% of the population. So, I don’t know what that is here. We have room to grow for a couple hundred thousand more patients.

Bill Marcus:                        Yeah, easily.

Ally Marotti:                       It’s what folks are expecting.

Kris Krane:                          Yeah, easily.

Ally Marotti:                       And growers and operators are ready for that, but they’re preparing for that. We can get into this later too, once we talk about the new legislation that was introduced over the weekend. But operators here are ready … they’re getting ready for recreational too. But they say that they can also handle a steady increase in patient count, because as the program grows, and if recreational comes on line, like it’s expected to. The medical program will also grow as well. Just because more people are aware of it. There are still people in Illinois that don’t even know we have a medical program. So education’s a big part of what’s keeping that growth at bay right now. So we’ll see.

Bill Marcus:                        But the opioid thing, and I’ll kick it back to you Kris, because you pointed something out earlier, it’s still disproportionately beneficial to the people who are less disproportionately affected by what’s going on. There are not opioid patients in the south side of Chicago, because they don’t have insurance.

Kris Krane:                          That’s right. So my company 4Front, we own and operate Mission, which is the only dispensary right now in the south side of Chicago, down in South Shore. It’s a pretty economically depressed area by and large, and we’ve seen very little impact from the opiate bill. We have seen an increase in patients, we continue to see a steady increase. But we were seeing a steady increase before the opiate bill. It has gone up a bit since then, but from what we’re hearing, from talking with other operators, from the statistics that are being released, this bill has really impacted the dispensaries in the suburbs, and in the high income areas. Where you tend to have more people with opiate prescriptions. You tend to have more people with health insurance. It hasn’t really impacted the businesses nearly as much in lower income areas where you don’t have as many people with those prescriptions. Where people are more likely already getting their opiates from the illicit market, so they don’t have the prescription. You just have not seen that increase in the number of patients in the lower income dispensaries.

So, all right, well let’s start moving to what’s coming here, the legalization bill has been introduced. There’s a lot of exuberance around it, and a lot of media in the last few days around this thing, and whether it’s going to pass. So, Ally, you’ve been covering this for a while. Do you want to sort of kick us off here, and give us some of the high level highlights of what’s currently in the bill?

Ally Marotti:                       Yeah, for sure. So, from a consumer standpoint, the bill would allow each person to possess 30 grams of cannabis, and that’s per household. And also you can grow five plants in a locked room, that’s not accessible to public-

Larry Mishkin:                    Not visible from the outside.

Ally Marotti:                       From the outside, yes. From the business-

Kris Krane:                          They’re literally legalizing closet growers?

Ally Marotti:                       Yeah, basically. I think it will be interesting to see if more clarity comes out around that. Because I feel like there’s some natural light that might be needed in there.

Kris Krane:                          Yeah, it would be nice if you could grow some in your backyard.

David Friedman:               We sell some great grow lights.

Ally Marotti:                       I think about my little plants at home, they would not do well in a closet. Not cannabis plants, regular plants.

Kris Krane:                          Wink, wink.

Ally Marotti:                       Right, but so on the business side, there’s a huge social equity aspect of it. Right now the diversity numbers, as far as operators go in the industry, are not great. Part of that is because there was such a high barrier to entry. Such high application fees, licensing fees, that type of thing, with the medical program. So there’s a huge portion that addresses that. They’re looking at bringing in some money from the medical program, and then the recreational program, to back loans and financially subsidize some of these folks that want to get into the industry.

They’re looking at letting the medical operators, now the growers become growers, and keep those licenses just at those numbers for the first year. The bill is over 500 pages long, so there’s a lot more to it than that, but hopefully that’s a good overview.

Kris Krane:                          Yeah, that’s great. Anything anyone else wants to add? Any provisions that we didn’t hit on yet?

David Friedman:               I think the 800,000 previous convictions is a big deal, very big deal. I think you were talking about that in terms of Larry, what that means for the economy, the local economy’s. Especially in the areas where you are in the south side, where it’s economically depressed. These people can’t get jobs. This is a real stigma for a lot of people. That’s a huge portion of population, 800,000.

Kris Krane:                          800,000 is a lot of people. It’s a state of 13 million people that’s one in-

David Friedman:               Right, it’s 78% of the population.

Kris Krane:                          … it’s a big percent of that. I know when you’re saying 800,000 people, we’re talking about record expungement here, right? So can we talk through the mechanics of what that would look like, what expungement itself would look like? Is it something where folks are going to have to apply to the state to get their records expunged? Or is the onus on the state to go and find anybody with a cannabis conviction?

David Friedman:               Actually, the way it’s written is the police departments are going to be responsible for identifying people in their communities, and then they’ll run the program to get the expungement’s through … I’m sure they’ll come up with a committee, or whatever it is. That should be pretty interesting.

Kris Krane:                          I imagine that’s not going to be popular amongst a lot of law enforcement agencies.

David Friedman:               I can’t see it being very popular.

Larry Mishkin:                    Well, I don’t think it’s going to popular among a lot of the people in the communities either. They have to go back to the people that put them in the system in the first place, to get out of the system. I think there’s a lot of details they’re going to still have to be worked out about this-

Kris Krane:                          No doubt. As an old school activist, and advocate on this, in my mind the onus should absolutely me on the state. If you have a conviction, and the state put you through the ringer on that, the onus should be on them to find the-

Larry Mishkin:                    They have all the records too.

Kris Krane:                          Yeah, exactly. They have the records. It should not be on the individual to have to go and seek out the state, and get the records expunged.

Bill Marcus:                        I think it’s unclear. I think it’s the police departments are responsible for identifying the people in their community. I don’t believe that the people in the community have to go to the police stations to get it. It’s still a little unclear, well it may not be unclear, I haven’t read all 500 pages though.

Kris Krane:                          In most states, the way they’ve dealt with this is that the onus is on the individual with the record. To then apply to the state to have the record expunged, which most people are not going to do. Because they don’t know how, they don’t know the laws in place, there’s a fee generally associated with doing that. And like you said, not a lot of people are going to want to walk into the police station that put them in jail in the first place and say, “Hey, get rid of my record.” Particularly in communities that have been disproportionately targeted by law enforcement for marijuana crimes. Well, will no longer be crimes, right?

Bill Marcus:                        A lot of drug offenses. I think there’s two really interesting things about the social equity program though. One is expunging 800,000 felony convictions extends way beyond the cannabis industry. These are people who can’t get jobs because they have a felony conviction. Not people who can’t get jobs in the cannabis industry.

Kris Krane:                          Right, they can’t get jobs, that’s right.

Bill Marcus:                        The reach of that is significant, way beyond cannabis. The second thing is if you look at what’s going on in the legislature right now, and the people that are speaking out against the bill, Madigan primarily. The biggest pushback is coming from the leniency around the record expungement, and the social equity program.

So there’s going to be some infighting in between the moderate democrats and the liberals that control two thirds majority of both houses around this social equity component. It’s going to be really interesting to see how that plays out. It’s not going to be a very popular piece of legislation to be on the wrong side of.

Kris Krane:                          Like we were talking about earlier, this is basically what sunk legalization in New Jersey so far. The parallels between Illinois and New Jersey are pretty stark. You had both states where you had a democratic either super majority, or a very strong majority in both houses. A republican governor who had done everything he could to try and stifle the medical program. Ended up either losing to, or in Jersey’s case, either retired and then democrat in both states ran on legalization as a top priority. Pushed a bill in their first year. Lot’s of exuberance that it was going to get passed. Well, we’re year two in Jersey now, and that bill still hasn’t passed. My understanding is a big piece of that was this issue around expungement.

From what we hear, behind the scenes, there likely were enough votes to get it passed there in the house, but they were a couple of votes short in the senate. That was over this issue of expungement, and where the threshold should be. In New Jersey, it was any marijuana crimes that included offenses up to 500 pounds.

Bill Marcus:                        Five pounds.

Kris Krane:                          Five pounds, sorry. 500 pounds would be a lot.

Bill Marcus:                        Pretty much [crosstalk 00:19:38].

Kris Krane:                          But for the number of more moderate democrats there who said, “That’s too much, I can’t get on board with this bill,” when they started doing some of the jockeying behind the scenes saying, “All right, how about if we lower it?” You started losing members of the black caucus, and Latino caucus that were saying, “No, this impacts members of our community, and we’re not going to lower this because we’re still going to have a lot of members of our community that are walking around with felony convictions.”

When you have an issue like this where you’ve got virtually no support from the republican side of the aisle. There are a few … there were a few in Jersey, there’s going to be a few here. But by and large, this is a battle that’s playing out within the democratic party. You don’t have a whole lot of wiggle room if you have virtually nobody from the other side. You’ve got moderate democrats that are going to want it to be a more … a little bit more of a restrictive program. Then you’ve got progressive democrats that are going to want to see it much more free, and open. You’ve got, in both states again, very strong, very large Latino caucuses, black caucuses that want to make sure that the interest of their communities are being represented. In some cases that conflicts with what the moderate democrats are going to want to see.

So I want to come back to the social equity question here in a minute, but I think this is probably a good time to sort of ask for predictions. Like what are folks thoughts here on how likely this thing is actually to get passed this session?

I want everyone on the record here.

David Friedman:               I think given the amount of time we have, and we do have a good amount of time-

Larry Mishkin:                    This session’s over in a month, isn’t it? We only have a month for this session.

Kris Krane:                          Less.

David Friedman:               For this month.

Kris Krane:                          Pritzker’s saying it’s going to be passed succession, and it will start in January first. Is that going to happen?

David Friedman:               I think that it’s going to happen. I think that … my reasoning for it also has to do with the fact that social inequity is a big, big deal. Pritzker really behind the scenes, I’m told, has worked very hard on this.

Kris Krane:                          No doubt about that.

David Friedman:               Rep Kelly, and others. Also the fact that the main constituents in Illinois have worked hard from a corporate standpoint, in terms of lobbying as well. I think it will pass. I want to … I’ll let the rest of the panel talk, and then I want to bring up one more point.

Kris Krane:                          All right, we got one yes.

Ally Marotti:                       Okay, so I’m going to remain objective as a journalist, and not say one way or the other if I think it’s going to pass or fail. But I will tell you what I know, and I know that the sponsor’s of this bill have been working on this for a long time. This wasn’t something they started putting together as soon as Pritzker got elected. They’ve been working in the space, on the medical side for years.

The social equity part of it, that seems to be drawing some ire from some folks now. Nitpicking what’s wrong with it, what can we do better? The sponsor’s again, worked with folks, minority groups, the Illinois black caucus. A lot of different folks came to the table to put this bill together. I’d imagine that’s why it’s over 500 pages long. So I think that’s also part of why they waited so long to introduce it in this session. We only have a few more weeks to get it passed. I think it’s partially because they hadn’t reached a decision on stuff. I was reporting out a diversity story a few weeks ago, and at that point they hadn’t nailed down the social equity part of it.

So I think this is something that they had a lot of people weigh in on, and they thought, “How are we going to get this passed? How do we need to write this language to get it passed before they put it in there?”

Kris Krane:                          So take that as a yes?

Ally Marotti:                       We’ll see, we’ll see.

Larry Mishkin:                    I would like to be optimistic, but I recall all of the problems that surrounded the roll out of the medical program. It took longer to pass the legislation than they thought. It took forever to get the administrative regulations issued. Long before we’ll ever have an adult use sale, all of these things are going to have to be worked out.

I think it’s very, very optimistic of them to believe that they can get it passed this session. We don’t have any final word on what Michael Madigan has said. We all know that nothing’s going to happen in this state, unless Michael Madigan supports it. I think part of what’s going on is he’s trying to get a feeling of the pulse of that part of the state that lives south of I-80. Whether the people down there are really going to put their support behind this.

I can’t speak to that one way or the other, because I don’t know the answer. But, there are a lot of issues out there that do have to be addressed. I’m not saying it can’t be done, but I see it as being somewhat problematic. The social justice side of it is certainly the bedrock in the foundation of this plan. But even that becomes problematic in terms of … is every group that feels like it should be supported getting supported?

I’ve talked to a number of women who are in the cannabis industry, and they’re very distressed by the fact that the social equity portion says nothing about women. It doesn’t provide that there should be loans, or situations to allow women owned businesses to be able to get a head start. Will that go anywhere in terms of tripping this up? Again, I don’t know. But there are a lot of issues out there that we haven’t been hearing about. They’re going to have to be resolved before the program can get going.

Kris Krane:                          Is that a no?

Larry Mishkin:                    That’s a, I don’t think so. But I’d like to be wrong.

Bill Marcus:                        I’m going to be a firm no, but I’d like to be wrong. I think the bottom line, as Larry said, nothing gets done in this state without Madigan behind it. He has come out saying that he’s not in support of the bill because of the extensive nature of the felony expungement’s. Both the Sun Times, and the Tribune have come out and said, “We’d like to see it slowed down.” The head of the NAACP has come against it here, because they don’t think it goes far enough. With three weeks left in this session, I don’t see the state of Illinois moving that fast. Will it happen this year? In the next session? And is Pritzker’s goal to get this thing forced to a floor vote so that he can flush out everybody’s position? I think that’s probably more in line with his thinking as a business man. I’m going to say unless something drastic happens, and Madigan comes out and says, “Hey, this is what I want,” and he gets it, it’s a no for this session.

Kris Krane:                          And I’ll put myself on record as well. I think it’s a probably not. I also very much hope I’m wrong. But despite all the exuberance, no state has passed legalization through the state legislature yet, period. Vermont came closest. Some consider that legalization, I’d call it like super decorum. Basically it’s illegal to posses up to an ounce, to grow up to six plants, to gift it to friends. But there’s no legal commercial cannabis in Vermont. I think they will be the first state to do it. I think it’s going to happen this year in Vermont, because it’s another step. They’ve already taken that first step.

It’s really hard to get any semi-controversial legislation passed the first time it’s introduced. Because of all these issues that we’ve been discussing. There are constituents, there are representatives, there are representative constituents that have specific concerns that may conflict with other representatives concerns. Even if they in theory support legalization. It’s very hard to get a majority to yes in the first go round. It’s the reason why it hasn’t happened yet anywhere, despite the fact that nine states and D.C. have now voted for it. We’ve adequately demonstrated that the public is in support of legalization, but the legislature’s haven’t quite figured out how they can get consensus amongst the legislators to get it passed. So I think it’s a real uphill battle to get this done this year.

Bill Marcus:                        And this is Illinois, it’s very much of a, “What’s in it for me?” So everyone of these voting congressmen, and voting senators still has the opportunity to pass the hat around and decide what it is that they want out of this. I don’t think there’s enough time left for that to happen.

Kris Krane:                          Now to be fair though, they did get some of that already. Part of what governor Pritzker did, and part of the reason why they waited so long to introduce this bill was that they wanted to get the budget passed first. The budget has money allocated for pet projects all around the state that is tied directly to cannabis revenue. So if those members don’t then vote for cannabis legalization, they don’t get the money for their pet projects in their districts. Does that make anybody a little more optimistic or? It doesn’t make me, but trying to come around on the rosy side of this here.

Bill Marcus:                        I think it’s certainly a benefit towards getting a yes vote, but I just don’t think it’s enough yet. I think that there’s more than just $120 million of allocation of tax resources, and other things that these legislators are going to want baked into this bill. It’s an important bill, it’s going to get stuffed with all kinds of things before it’s passed, in my opinion.

Larry Mishkin:                    Well, the other thing is that he’s making all of these predictions about how much revenue he’s going to generate off the program, and the program hasn’t started yet. I think that was a problem when the medical program rolled out too. That I saw investors who would come in, and say, “We’re going to make this much this year, and this much the next year,” and the program hadn’t even gotten off it’s feet yet.

So it’s optimistic for Pritzker to kind of guess how much money he’s going to get out of this program. But given the slowness with everything else, I think it’s overly optimistic to suggest he’s going to be getting that much money initially.

Ally Marotti:                       I do think that most of the … I could be wrong about this, so correct me if any of you guys know, but I think some of the budget set aside that he had were from the licensing fees?

Larry Mishkin:                    Yes, that’s true.

Kris Krane:                          I believe that’s right, yeah.

Bill Marcus:                        Those weren’t budgets set aside, those were for the social equity program, right?

Kris Krane:                          Oh.

Ally Marotti:                       No, I’m talking about in Pritzker’s budget for 2019. He had … yes, he had some line items that he took directly from licensing fees for the recreational program. But doesn’t the bill say that there’s no new licenses that are going to be awarded yet this year?

Bill Marcus:                        No new one’s, but the existing license holders are still going to have to pay for their recreational license.

Ally Marotti:                       Okay.

Kris Krane:                          And even for [inaudible 00:29:18], let’s get into that. We want to talk about licensing. My understanding is we’re really not looking at new licenses for a year, right?

Bill Marcus:                        That’s my understanding. No new licenses for a year, for anything. $75 after a year for dispensaries, and $40 for craft cultivation, processing, and transportation after a year.

Kris Krane:                          Okay, so let’s say on the cultivation side first. So that’s 40 new craft cultivation licenses a year after the bill passes. What about the existing operators? Those get grandfathered in automatically?

Bill Marcus:                        That’s my understanding the way the bill’s written now, they pay their fee, and they’re automatically granted a recreational license with unlimited capacity.

Kris Krane:                          Mostly, yeah.

Bill Marcus:                        Yeah, devils in the details but generally speaking, there’s some qualifications-

Kris Krane:                          Essentially the idea is-

Ally Marotti:                       Have you guys read all 500 pages of the bill?

Bill Marcus:                        You’re lawyers?

Kris Krane:                          Flip the switch for the existing license holders, wait a year, then grant some more licenses. Which, look, there actually is a good public policy rational. I say this full disclosure. We are one of the existing license holders. Both in cultivation, and retail. I try not to speak out of self interest here, I’ve actually argued with my colleagues in a number of states on whether or not we should add more licensees. I tend to fall on the side of I think we should, and we’ll get into that in a moment.

But there is a policy rational for giving a headstart to the existing operators, right? Number one, they did take these massive risks at a time when the program was non-commercial, and it bled money for many years. So give them a little bit of a headstart to recoup some of that.

But the biggest one is they have the infrastructure in place. They’re already growing cannabis, and if you want the program to get up and running, and you want to provide cannabis to the public as quickly as possible, let the folks who are already doing it flip the switch, and start growing for adult use as well. They can get to market faster. Even if you start issuing new licenses right away, there’s still an administrative process. There’s still an application process. Then they have to go through zoning, and permitting. You have to actually build out. Plants take four months to grow. So even once you get plants in the ground … realistically, best case scenario, it’s a year after licensing starts before anybody else is really even online.

So the initial folks are going to have an advantage no matter what. Again, there’s a public policy rational for that. My question though is, is there going to be enough supply to meet demand in this market? Given how few new licenses we’re talking about issuing?

Larry Mishkin:                    I think with respect to demand, initially I’m not particularly concerned about that. Because most of the grower’s are not growing on anywhere close to the full square footage that they currently have. Because as it was accurately pointed out earlier, there just weren’t enough patients to justify that. It’s going to take a while for new cultivation centers to get up to speed anyway, so we’ll find out relatively quickly whether the current cultivators can do it.

The thing that we were all talking about that I’m a little surprised is, not immediately adding more dispensaries. Because some of the dispensaries that currently exist, certainly on the north shore, from time to time find themselves running out of product. Over marketed by people who are choosing those particular dispensaries, and I’m not sure that we can get by on 50 or 55 dispensaries for the entire state if we’re going to have adult use.

Kris Krane:                          We have 55 retail outlets for a state of 13 million people. And even though they’re going to grant 75 more a year later, again-

Bill Marcus:                        Those are not enough.

Kris Krane:                          … it’s going to be at least a year before those stores start getting open. If past is precedence for other states, it will probably be longer.

Bill Marcus:                        But I do think they have to protect against a rush of inexperienced operators flooding the market with product that has all kinds of problems. They don’t have the resources allocated. They don’t have the revenues to be able to police all of this. So I think there’s some concern around if we let too many people in too quickly, how are we going to manage the market as well?

Ally Marotti:                       There’s definitely some concern around that, I’ve heard from growers. The other thing to point out is that many of these big multi-state growers that are based here, and have operations here, have been expanding their grow facilities, readying for this since last summer.

Some of that was to prepare for the growing medical program, like we talked about earlier. If you think about these facilities, most of them in Illinois … I’m not sure if any of you have ever visited one, but there are these big unmarked facilities that just look like warehouses in the middle of nowhere. But many of them, when they started out, they did build outs, and had phases. And for many of them, they only had a few of their growing rooms open. They’ve been expanding over the past year to add more grow rooms. Build out the whole

Kris Krane:                          But even then, but let’s stay on this. So let’s say you’ve got basically 15 cultivators now, and a few of them have multiple licenses. So really 19 essentially that have licenses. So you’re talking about 190,000 square feet. Total canopy space, 190,000 square feet. Will that serve a market of 13 million people plus however many tourists come to Chicago every year? Is that enough?

Bill Marcus:                        So that’s 1.9 million square feet if they’re fully built out. 100,000 per-

Kris Krane:                          100,000 per, right.

Bill Marcus:                        So it’s 1.9 million square feet. It’s still, I don’t think is enough to support-

Kris Krane:                          Still, is that enough to supply the market?

Larry Mishkin:                    Kris, I’d like to throw that back at you, as a commercial grower, what do you think?

Kris Krane:                          I don’t think it is. That’s why I asked the question, I don’t think it is.

Ally Marotti:                       We’ve seen a couple of studies come out on this. There is a study sponsored by the industry. There is a study sponsored by the sponsors of the bill. One of the studies found that for at least the first few years, the current growers could supply. That’s because it takes a few years for a market to reach full maturity. I think it took Colorado four or five years, they say. I guess that’s where we’re at sort of right now with legalization in Colorado, four or five years in. I think it’s reached maturity now, maturity being full demand.

We hear a lot of stories about dispensaries selling out the first day that sales start. But also, something to consider is that the first day, the first week sales start, there’s going to be more sales than there would be even two months into the program. Just because there’s a rush. When a new store opens, when a new product is available.

The study that the sponsors of the bill put out there was done by a firm in Colorado. They did make a lot of comparisons to the Colorado market, and Illinois is very different. We have a larger population, it’s dispersed differently. There’s a lot of things to consider here. I think-

Kris Krane:                          And you’re not going to have 1.9 million square feet. Not all of those growers-

Bill Marcus:                        They’re not going to max out in the first year.

Kris Krane:                          Our building maxes out at 94,000 square feet, and that’s not all canopy space. That’s your total footprint. That’s the total footprint. So that includes the processing areas, and hallways, and everything else. It all has to fit within the physical building that we have. Are we looking at a major supply problem in Illinois if this bill passes as it currently stands?

Ally Marotti:                       I think that the biggest concern would be, and I could be wrong about this. Again, would be the dispensary side of things. Because that number seems way off to me from all the studies that I’ve seen. To only have 55-

Kris Krane:                          And then 75 a year later, which will take them time for them to come on line as well.

Larry Mishkin:                    We saw that in Massachusets when they first rolled out adult use. They only had, I think, initially three dispensaries-

Kris Krane:                          Two to start.

Larry Mishkin:                    … and none of them were located in major metropolitan areas.

Kris Krane:                          The first one in Boston just opened about a month ago. The Boston Metro area in Brookline.

Larry Mishkin:                    Right. But prior to that, you had people getting up at 3:00 in the morning to drive to these locations to get there before they ran out of product. I think it’s a natural part of-

Kris Krane:                          They all have limits in Massachusets, products. So if you go in as an adult use consumer, to buy cannabis at one of the legal dispensaries in Mass, at this point, still virtually everyone of them will have a limit on how much you can purchase that’s well below what the state limits are. It’s the only way they can keep product in house.

Ally Marotti:                       I think with dispensaries too, if you look at the map now from where the 55 dispensaries are located, the map of Illinois, there are some big holes. Part of that is because they were, I believe, a handful of licenses that were never awarded, or were awarded and the dispensaries never opened. Mission is the only one sort of on the south part of the city. So there are some holes there, even considering the population. Obviously in rural Illinois, there’s a population disparity there, but there are some holes. So that would be something else.

David Friedman:               I think erring on the side of caution, and Larry you’re the most legally trained here, if the program is going well, and there’s huge demand, can’t they amend this program at some point?

Larry Mishkin:                    Always. They could always amend anything.

Kris Krane:                          But that takes time. You got to issue more licenses, they got to build out. You got to recognize, it’s from licensure to opening, it’s best case it’s a year.

David Friedman:               What I think we got right here in Illinois, and I can’t underscore this enough, is I look at this room and I see maybe a couple of people of color here. Is that we got the disenfranchised right. That’s a big deal here to me.

Kris Krane:                          In the bill, you mean?

David Friedman:               Yeah.

Kris Krane:                          It’s not in the medical program.

Bill Marcus:                        That’s just the way that it is.

David Friedman:               No, in the bill, if that passes. We were talking about the odds of the bill passing, right? There’s other incentives. At some point, it might be one year, two years, four years out where demand meets supply, there are, I believe, those that read the bill, all 500 pages, some benefits including people of color, and disenfranchised in terms of lower fees. As well as I think lower taxation.

Kris Krane:                          Right. The bill’s trying to address the fact that folks from disproportionately impacted communities, primarily people of color, people from communities that are most targeted by the drug war, have an opportunity to participate in the new legal economy, which is something I think that everybody would admit the medical program did not do well. There’s very few people of color, very few women represented amongst ownership in the current medical industry in Illinois. And there’s a recognition that we need to create avenues to entry into the industry. Particularly when we’re talking about a drug war, marijuana prohibition that’s been essentially fought on the backs of young people of color. That there needs to be an avenue for these folks to participate.  I will say I’m skeptical that the provisions in the bill will really achieve this goal.

Bill Marcus:                        I agree.

Kris Krane:                          I think it’s laudable they way that they’ve done this, and frankly I’m not sure that there’s a way that they could write it that would achieve the goal.

Bill Marcus:                        Look, a 5,000 square foot facility-

Kris Krane:                          We’re talking about craft grows. How can a 5,000 square foot craft grower compete with 100,000 square foot-

Bill Marcus:                        Exactly. And how much of a craft grower market is there going to be? We got a lot of craft brewery’s in Chicago so-

Kris Krane:                          There will be a craft grower market. But the problem is most of the craft growers are not going to grow craft quality cannabis.

Bill Marcus:                        Correct.

Kris Krane:                          Especially because you have a small grow doesn’t mean you’re a great grower. So yes, the smaller growers that grow the best quality product, there will absolutely be a market for that product. But if they’re growing mediocre quality product, they cannot compete on price with somebody’s who growing in a 100,000 square foot facility. So that will make things very difficult.

My concern though is it’s expensive to get these businesses up and running. Even a 5,000 square foot craft grow is probably going to cost close to $1 million to get operational. A dispensary is still going to cost you, best case scenario a half a million dollars to get operational. Where does that money come from? The bill sets aside $20 million to go into a fund to help fund social equity applicants. That’s 20 grows at best, absolute best case scenario that will cover 20 grows.

So where does the money come from to insure that the social equity applicants can actually get their businesses operational?

Bill Marcus:                        And that’s why you have the … same they had in Oakland where you’ve got larger companies, and business in affluent investors trying to find minorities in equity participants to front for them. Then you have to start to police that, and in the application process, that becomes very difficult. You run into problems.

Kris Krane:                          Very difficult.

Larry Mishkin:                    Well, there were bonus points, if I recall, in the medical applications for-

Kris Krane:                          There were bonus points, yeah. It didn’t do a whole lot.

Larry Mishkin:                    Right, it didn’t do a whole lot. I don’t like to use the term social engineering, but part of what they’re trying to do here is create a solution … I admire what they’re trying to do, and I think it’s the right way in theory. But whether or not it can actually play out specifically, and create the type of opportunities that they want, we’ll have to see.

Ally Marotti:                       So this is just speaking from my reporting, this isn’t an opinion or anything. Many other states have started thinking about the social equity points when they came on line with their medical programs. Many states east of here, Ohio for example, New York, I believe. A lot of them built into their application programs, social equity points. They awarded points for certain things. They require companies applying to tell them how they would make sure their workforce was diverse, and layout that business bend from the get go.

Ohio, I believe, awarded a certain number of license to companies with diversity ownership, that sort of thing.

Kris Krane:                          Pennsylvania did a lot too.

Ally Marotti:                       Pennsylvania, exactly. Speaking with the law makers here when they were crafting this bill, they were saying, “Other states have tried, but no one’s gotten it right yet, and we want to be that state to get it right.” So some of the things that they were telling me was that … like you guys make good points, but also that’s having other licenses, having other types of licenses … so with the medical program right now, we have growers, and sellers, and that’s it.

So with the recreational program, there would be delivery licenses-

Bill Marcus:                        Transportation and processing.

Ally Marotti:                       … transportation and processing licenses. So that offers more avenues of entry into the industry. There are also companies here, Revolution Enterprises is one of them, that have already started working with folks that are in these opportunity areas, that are interested into get into the industry, and weren’t able to get in for whatever reason on the first time around. They’re helping to train them, just prepare them for the application process, which can take months to build a team to do that, train them on growing practices, and that sort of thing. Just to sort of help lower the barrier of entry.

So there’s a lot of industry operators that have already been thinking about this too. Again, take that with a grain of salt, because these are the big guys. And how would a new entrant ever be able to compete with a multi state operator at this point?

Kris Krane:                          I think what we’re starting to see … this becomes a very delicate balancing act, is this sort of partnership between MSO’s and social equity license holders. We’re starting to see this around the country. I’ve made the case, and shameless plug alert, I wrote a column for Forbes last year about how the lack of access to banking is particularly harming mom and pop owners, and social equity applicants.

If you are a license holder of say, one of … look, after they grant 75 licenses, we’re looking at around 130 retail licenses in a state of 13 million people. If you had one of those licenses, and this was not federally illegal, any bank in the state, any bank in the country would give you a small business loan, or a loan to get your business up and running. Access to capital would not be that challenging to someone in a market where licenses are so limited. But in the absence of that, where do you go for money?

I think we’re at a point now where we talk about how much more capital there is in the industry, and there’s a lot more capital we’ve seen come into the industry in the last two years. I would actually argue it’s more difficult for the mom and pops today to access that capital-

Bill Marcus:                        Completely agree.

Kris Krane:                          … than it was two years ago.

Bill Marcus:                        100%.

Kris Krane:                          Because you have so many operators that have so much experience. So if you’re a cannabis focus fund, or an individual angel investor, or a family office, which is where 99% of the money’s coming from these days. They’re going to be much more comfortable putting their money into a company that has a proven track record. Rather than to somebody that’s a start up that has to compete against these companies with a proven track record.

So right now, we’ve created a situation because of federal prohibition, and the lack of access to banking, where really the most viable source of capital for the mom and pop’s are the large players. That’s not inherently a terrible thing, if it’s done the right way. But it also can be very exploitative, and we’ve seen it done in a way that is not really beneficial for the social equity applicants where they really just do become front faces for the MSO’s, rather than the MSO’s empowering them to be actual entrepreneurs, and business owners in the space.

Larry Mishkin:                    I think you’re right, and I think what we’re really going to see here is that social equity can only go so far, as long as marijuana stays a schedule one. The elephant in the room, people have these conversations, but we don’t focus on enough is why is it a schedule one? Not the history, and all of that, but today-

Kris Krane:                          That’s another panel.

Larry Mishkin:                    Right. Today’s intelligent people who understand and know, and see why we haven’t been able to move this off of schedule one, and really off of schedule two. Once we can do that, and we solve the banking problems, that will solve these issues that we’re talking about. Because people will have access to small loans.

Kris Krane:                          So I think … Ally you have one more point to make, and then we’re going to open up for questions.

Ally Marotti:                       Sorry. I was just going to say that there’s also the folks here in Illinois that support opening up the banking system, but again, there are a lot of small community banks here that … a few that work with the industry now, but also many of them won’t touch it until it’s federally not a schedule one anymore.

Larry Mishkin:                    You have money laundering problems where these banks, and the bankers-

Ally Marotti:                       It looks like you’re [inaudible 00:47:13].

Larry Mishkin:                    Unless they pass the SAFE Act, which is currently before congress on the federal level, which would remove a lot of these restrictions in states that have programs. But in the absence of that, any banker who does the business, the individual banker, potentially faces criminal penalties.

So banks are very dis incentivized right now to do this. Again, if we take this off os schedule one, and schedule two, that problem goes away.

Bill Marcus:                        My daughter thinks that we’re an episode of Ozark. We spend all of our time trying to move money through the banking system. So now that the series has ended, they call me once a week to get an update.

 


Debra BorchardtDebra BorchardtApril 11, 2019
cresco4-1-1280x700.jpg

3min17460

Cresco Labs Inc. (CSE: CL) (OTCQX: CRLBF) received approval from the Illinois Department of Financial and Professional Regulation (IDFPR) for Cresco’s previously announced acquisitions of licensed medical cannabis dispensaries MedMar Rockford and MedMar Lakeview, located in the popular Wrigleyville neighborhood of Chicago.

According to Arcview Research, Illinois’ medical market is projected to have 126,566 legal consumers in 2022 and they are expected to spend approximately $400.5 million in 2022.

The company said that the IDFPR also approved Cresco’s acquisition of PDI Medical, a medical cannabis dispensary located in Buffalo Grove, Illinois, which was purchased by the Company in November 2018. The MedMar dispensaries are Cresco Labs’ fourth and fifth dispensary acquisitions in Illinois bringing the Company’s footprint to five dispensaries in its home state.

“Illinois is at the forefront of our nation’s evolution of the cannabis industry, and with these three dispensary approvals, Cresco has reached the maximum level of dispensaries any single company can own and operate in our home state,” said CEO & Co-Founder Charlie Bachtell. “We have already achieved the highest market share of any operator in Illinois and our prospects for accelerated growth are promising with the recent implementation of the Alternatives to Opioids program that began on February 1st. Illinois has opened access for patients by eliminating the three-month waiting period as well as requirements for fingerprinting and background checks for all patients with any qualifying condition. With a doctor’s approval, a patient can now receive a medical-use cannabis card in just one day.”

In addition to its five dispensaries in Illinois, Cresco operates three cultivation and processing facilities across the state.

Origin House Acquisition

Cresco announced recently that it was going to acquire Origin House in a deal valued at C$1.1 billion or C$12.68 per Origin House Share (based on the Exchange Ratio and the closing price of Cresco Labs Shares on March 29). The deal looks to be the largest public company acquisition in the history of the U.S. cannabis industry.

The combined company will be one of the largest vertically-integrated multi-state cannabis operators in the U. S.; a leading North American cannabis company, by footprint; and one of the largest cannabis brand distributors.


StaffStaffMarch 4, 2019
shutterstock_1075027280.jpg

21min6761
by Gaurav Dubey (Staff Writer, The Medical Cannabis Community, & Co-Founder/President, Karmik) & Dean Sangalis (Executive Content Engineer, Karmik)

Legalization of recreational cannabis may soon be coming to Illinois, with sales expected to begin in 2020. The IL medical cannabis pilot program has been successfully expanding and has set the precedent for well-regulated medical cannabis nationwide. As the prospect of legalization appears on the horizon, policymakers in Springfield have an incredibly important goal ahead of them: create an evidence-based and practical plan for legalizing a long since a once prohibited drug that is in the best interest of the people of IL.

However, after a longstanding ban on growers making political contributions has been lifted, there has been an increasing concern among patients, consumers and community advocates on what reportedly seems like an attempt to stymie economic competition through the lobbying efforts of a political action committee, as reported by the Tribune.1 Consumers in online communities have frequently expressed disdain in what they report may be a dangerous proposal for an otherwise flourishing opportunity for the state. Here are some trending observations made from the conversations taking place with the community at large.

From Grassroots Movement to Gassed Up Politics

While the incredible progress in cannabis policy has been the result of a powerful grassroots movement, critics report it is becoming evident that this may no longer be the case. Demand is the key issue moving forward, and unfortunately, when politics is involved, patients end up paying the price. Prior to 2017, it was illegal for medical cannabis license holders or their affiliated political action committees to contribute to political candidates.

This law was overturned at the federal level in 2017, allowing the current license holders in Illinois to use their influence to sway legislation, arguing that they should be grandfathered into recreational licenses and that no further licenses should be granted to any parties. Additional points have been presented in support of giving current license holders a chance to fully activate their production levels before approving new licenses. However, evidence supporting the idea that the consumer demand of a fully operational, adult-use legal market, could be effectively met by the current number of licenses issued seem to be lacking.

An Effort to Corner the Free IL Cannabis Market

If history has taught anything from the many states (and Canada) that have fully legalized cannabis, it’s that demand can, and will rapidly outstrip supply, sending the entire program crashing down. Nevertheless, a state trade organization, the Medical Cannabis Alliance of Illinois (MCAI), led by former state senator Pam Althoff, is advocating for restrictive legislation that could result in strictly limiting the IL market to its current players, barring any new licenses and thus, significantly increasing the probability of similar disastrous supply shortages taking place in Illinois.

New State Commissioned Study Shows IL Demand Will Exceed Licensed Growers’ Ability to Supply

In a new article published by the Chicago Tribune today, the results from an eagerly awaited study commissioned by state legislators are presented and it’s findings validate the concerns of many: demand will outstrip supply and the patients are the ones who will suffer the most.

The article states, “Legal recreational marijuana in Illinois could drive demand as high as 550,000 pounds a year, far more than the state’s licensed growers can supply, according to a new study commissioned by state legislators.”2

One can only hope our lawmakers and legislators will create new policy rooted in evidence, data, and facts. This isn’t the only report, however, that is sounding the alarm bells about MCAI’s restrictive proposal on new licenses.

They Who Control the Weed, Control the State

In such an event, this can be problematic on multiple levels. Logically, one can presume that within a functioning, Illinois adult use market, the demand will be related to the number of customers and how much they buy in a given timeframe. As of 2019, a recent report issued by Illinois NORML (formally the National Organization for the Reform of Marijuana Laws), details estimates for an adult use market in Illinois.

IL NORML Releases Extensive Report Confirming State Study & Warning of Supply Shortage

Using data from a 2014 White House report, Illinois demand is estimated at roughly 300,000 to 750,000 pounds. These numbers are based on self-reported usage statistics, potentially largely under-representing the actual market, along with an unaccounted five years of progress in educating the populace about the benefits and safety of cannabis. These numbers also do not account for tourism; with over 100 million tourists visiting the state each year. It can be expected that at least some tourists will visit dispensaries. The report notes that in Colorado, tourists accounted for roughly 9% of sales, and while it is clear the Illinois market will fluctuate from Colorado, correlating the data places Illinois demand at approximately 1.3 million pounds, annually.

Putting Politics Over Patient Concerns

The Medical Cannabis Alliance of Illinois is a state trade organization formed by some of the currently licensed growers in the state. When medical cannabis became legal in 2014, over 300 groups applied for licenses. Only 16 were ultimately issued. After the law change in 2017, the MCAI formed a PAC called the Illinois Relief Fund, where some growers immediately began donating, many contributing the maximum amount of $22,200.

It is important to note that not all license holders are members of the trade organization, or believe in restricting an already limited market. However, former state Senator Pam Althoff, the current executive director of MCAI, made the stance clear in the Chicago Tribune article, stating, “My organization believes they have the current capacity to meet the demand. Until we see substantive data that indicates differently, we support no new cultivation licenses.”1

IL NORML Report Clearly Reflects Need For More Licensed Growers in IL

The IL NORML report may arguably contain the substantive data needed for new considerations; where they’ve charted the increased scaling needed to more realistically meet the estimated market demand. Using even conservative estimates, the operation of every cultivating license would need to increase by 30 to 50 times or more. According to the report, a 30,000ft2 facility would need to become about 600,000ft2 to meet this demand, and it’s not likely that every facility can, or will want to expand their production. If demand does, in fact, outstrip supply, prices will be likely to skyrocket, and there could quickly be shortages as the whole state goes dry.

Download the full IL NORML study, il-norml-illinois-cannabis-industry-overview-and-analysis-v1.2!

IL NORML Report: A Closer Look At The Findings

MPG = Marijuana Policy Group; Tables Compare IL & CO; Bar Graph represents forecasted demand based on existing MPP (Marijuana Pilot Program) data and findings by MPG.

Despite Canada’s best efforts to supply the legal market, Canada began running out of cannabis after only 2 days of nationwide legalization.

The number of licensed dispensaries per thousand square miles in States with medical and/or legal cannabis programs. Despite its high population and expected demand, the state still trails sixth from the end.

The Issue is One of Medicine

Currently, Illinois has roughly 50,000 registered, medical marijuana patients. Average sales are roughly 15,000 pounds per year, and that is with around 60% of registered patients buying in any given month. Going from 30,000 regular customers to millions of customers is a massive increase. If the supply is indeed unable to meet the demand, we could suddenly have a medical crisis where patients won’t have access to their medicine, or they’ll be forced to pay exorbitant prices.

This is one of the greatest fears patients have, and could easily have the unintended effect of invigorating the illicit market, thus funneling tax revenue away from the state as people seek less desirable avenues for relief. Adding insult to injury, in other states, there are efforts aimed at removing consumers’ ability to grow their own medicine.

Those using cannabis for nausea from chemotherapy, TBI, MS, Fibromyalgia, etc. for example, would have compromised access to their medicine, and those with rare forms of childhood epilepsy requiring CBD for maintenance could be placed at a dangerous level of risk.3

The most vulnerable patients would likely be forced to go back to more cost-effective pharmaceuticals, regrettably reverting the progress they may have already made in reducing, or in some cases entirely eliminating their need for prescription medications. Due to current federal laws, state dispensaries must buy their supply only from licensed growers within the state, some of which make up the MCAI.

If you Grow, They Will Go: There is Plenty Opportunity For Everyone

Demand has not failed to outstrip supply in California, Colorado, Michigan, and Canada, with Canada burning through a 200,000-pound surplus in just six days.4,5 Patients feel it can happen in Illinois as well, prompting the conversation about legislative options and possible alternatives.

The medical cannabis movement has always been a patient-driven focus. It was inevitable that, once regulations began to ease and the possibility of legalization appeared, the “green rush” would begin to ensure nationwide. There are potential options available to enable the market to stabilize itself, without relying on what seems like a scarcity mentality, to limit production and control the progress of a market that has only recently begun to flourish.

Different States, Different Approaches, Same End Goal: To Benefit the People

Other states have implemented different approaches to the licensing dilemma. Some states give dispensaries the option to have their own growing operation, as they’ve already been licensed and vetted by the state. In some states, they offer home grow licenses for medically registered individuals where they can grow a limited number of plants for personal use, and if they desire, sell any excess.

What needs to be consistent, however, is the proper testing and management of all growing operations, ensuring that both patients and consuming adults have access to pure, uncontaminated products. Nevertheless, critics of the recent news believe that by providing such propositions to take place, the state could inadvertently e crush the potential for new licensees to enter, innovate, and benefit from the market opportunity, while at the same time ignoring the soon-to-be massive demand influx that is projected to be right around the corner.

Success Today Does Not Guarantee Success Tomorrow

Bumps aside, the medical program in Illinois has turned out to be successful thus far, in that there have been no outrageous cases of diversion, theft, or notable public events. While the program has regrettably struggled with the policy issues at hand, the program shows these issues are becoming more evident.

If allowed to continue unaddressed, patients, consumers, doctors, advocates, and others in support of the program fear that if the consequences stand to be true (as they have many times before as witnessed in other states and Canada that have implemented full cannabis legalization), the program could very well neglect the people it was originally intended to protect.

What do YOU think? Have thoughts on the conversation? We want you to contribute to the dialogue, so chime in and share your feedback in the comments on our page. Be sure to also join the IL Medical Cannabis Community Facebook Group to ask questions and stay engaged in the discussion!

 

Works Cited

  1. McCoppin, R. Medical marijuana growers are lobbying for licenses that also would allow them to control supply of recreational pot in Illinois. chicagotribune.com Available at: https://www.chicagotribune.com/news/local/breaking/ct-met-marijuana-companies-lobbying-to-limit-recreational-licenses-20190214-story.html. (Accessed: 26th February 2019)
  2. Keilman, J. Demand for legal marijuana in Illinois would far exceed licensed growers’ ability to supply it, study shows. chicagotribune.com Available at: https://www.chicagotribune.com/news/local/breaking/ct-met-illinois-legalized-marijuana-study-20190228-story.html. (Accessed: 1st March 2019)
  3. Supply challenges in cannabis industry affecting medical patients. Winnipeg (2018). Available at: https://winnipeg.ctvnews.ca/supply-challenges-in-cannabis-industry-affecting-medical-patients-1.4175718. (Accessed: 26th February 2019)
  4. California Might Run Out of Legal Cannabis by Summer | Leafly. Available at: https://www.leafly.com/news/politics/california-will-run-out-of-legal-marijuana-by-summer-legal-fix-in-works. (Accessed: 26th February 2019)
  5. Canada Nearly Runs Out of Weed After Marijuana Legalization | Fortune. Available at: http://fortune.com/2018/10/21/canada-runs-out-legal-weed/. (Accessed: 1st March 2019)

Debra BorchardtDebra BorchardtDecember 24, 2018
Ascend-1280x940.jpg

4min13660
Multi-state operator Ascend Wellness is expanding into Illinois through a long-term lease  with Innovative Industrial Properties (IIPR) of a cultivation facility that Ascend will operate.  The deal, along with the definitive agreement to purchase HCI Alternatives, will create Ascend Illinois. The deal for an undisclosed amount is expected to close in early 2019.
The company said that the facility is projected to create new jobs and increase supply in the state, where medicinal use of Cannabis was first legalized in 2013, and made available to patients in 2015.
The cultivation facility is located in Barry, Illinois and is 75,000 square foot. It will be one of sixteen cultivators in operation in the state. Ascend Illinois says it will have a unique advantage to lead the state by filling growing patient demands.
“The passing of the opioid bill will lead to significant growth in the Illinois market next year,” said Founder of Ascend Wellness, Abner Kurtin. “Ascend is excited to bring a wide variety of branded product to enhance the experience of the Illinois consumer.”
HCI Alternatives, which is also based in Illinois has two two retail facilities in Springfield and Collinsville, as well an online cannabis educational resources website. HCI’s current customer base captures about 10% of the total market share in the state.
“We are gratified to be part of Ascend Illinois,” says Chris Stone, HCI’s CEO. “Illinois, like the rest of the country, has been plagued by the opioid epidemic, to which cannabis provides a safer and non-addictive alternative to pain management.”

Earlier this month, Ascend announced that it has raised $40M. The company has been developing licenses in three populous eastern U.S. states: MassachusettsMichigan, and Illinois. Combined, they create the largest market east of the Mississippi, which is equivalent in size to California or Canada, two of the most profitable cannabis regions in the world.

The companies that invested in Ascend include some of the biggest names in cannabis investing like Poseidon Asset Management, Salveo Capital, JM10 Partners, and Shire Capital Advisors. The company said proceeds from the capital raised would be used to build out locations in these markets and acquire future assets.

Ascend Wellness currently has plans for three high-end, licensed adult-use cannabis retail locations in three metro-area Boston locations. Additionally, the company has plans to develop a significant retail presence throughout these emerging markets as it solidifies itself as a leading U.S. cannabis operator.


Debra BorchardtDebra BorchardtOctober 3, 2018
medmen2.jpg

6min13140

MedMen Enterprises Inc.  (MMNFF)  signed an agreement to purchase Scottsdale-based cannabis company Monarch from WhiteStar Solutions. Monarch is a licensed medical cannabis license holder with dispensary, cultivation and processing operation. In addition, MedMen will acquire WhiteStar’s exclusive co-manufacturing and licensing agreements with Kiva, Mirth Provisions and HUXTON for the state of Arizona.

MedMen will pay WhiteStar approximately 80% in stock and 20% in cash in an undisclosed amount. The stock consideration will be satisfied by way of issuance of shares of MedMen Enterprises, Inc.

“Our strategy has been to establish our brand in the primary markets of California, Nevada and New York,” said Adam Bierman, MedMen chief executive, and co-founder. “We have a leading presence in those primary markets and we are now ready to expand our reach. Arizona, with its robust medical marijuana program and connectivity to California and Nevada where our brand is already strong, makes this a great fit.”

Monarch was founded in 2013 and according to the company statement is among the top medical marijuana dispensaries in the country and is the first cannabis dispensary to break ground in Scottsdale with impressive product offerings in its portfolio and a run rate revenue of over $10 million. Monarch is licensed to operate a 20,000-square-foot cultivation and manufacturing facility in Mesa, Arizona. As a wholesaler in the Arizona market, Monarch distributes branded products to over 60 dispensaries in the state.

Seven Point Acquisition

In addition to the Arizona acquisition, MedMen is also purchasing Chicago-based dispensary Seven Point for an undisclosed amount of cash at closing, deferred cash, and shares of MedMen Enterprises, Inc.

“This acquisition brings the MedMen brand to yet another major stage,” said Bierman. “MedMen has established a presence in the primary markets of California, Nevada and New York. Our strategy has been to put our brand in high visibility commercial districts in popular locations like Beverly Hills, Manhattan, Las Vegas, and Oak Park, just outside Chicago, fits the mold perfectly.”

Originally, MedMen had been expected to remain in the key markets of California, Nevada and New York. However, it recently made a move towards Florida and this week’s acquisitions signal an additional effort to move beyond those heavy tourist locations. Seven Point is located in a high foot traffic shopping district among popular restaurants, cafes and major retailers like Whole Foods, Gap and Pier 1.

“Seven Point is proud of its strong commitment to the local medical patient community and the loyal following we have built over the years,” said Brad Zerman, chief executive of Seven Point. “MedMen will continue that tradition while bringing its industry-leading retail operations and
commitment to quality and service.”

Loan Facility Is Closed

Also this week, MedMen closed a C$93,822,023 (US$73,275,000) senior secured term loan facility with funds managed by Hankey Capital and with an affiliate of Stable Road Capital as the largest loan participant.

The principal amount under the Facility will accrue interest at a rate of 7.5% per year, paid monthly, with a maturity date of 24 months following the date of closing on October 1st, 2018. The Facility will be used for acquisitions, capital expenditures, and general corporate purposes.

“This industry is more investable than ever, and this loan is reflective of that progress. Hankey Capital and Stable Road Capital’s knowledge of this sector and their creativity allowed us to structure one of the first true senior secured loans in cannabis,” said Bierman. “Our
operations in the primary markets of California, Nevada and New York are robust, and now we are turning our attention to the most promising and strategic markets across the country and the industry.”

The loan follows a recent bought deal that raised C$86 million (US$67 million). MedMen may repay the loan at any time and from time to time, in whole or in part, with a prepayment penalty of 1.0 percent of the outstanding principal amount repaid if repaid before December 31, 2019.

MedMen said it is also planning the structured sale to a special purpose real estate entity focused on the cannabis sector of real estate assets it currently owns in key markets.

“MedMen has an unmatched track record of execution in this fast-growing industry,” said Stable Road Chief Investment Officer Brian Kabot. “We are proud to facilitate MedMen’s growth with capital that can enhance value for all stakeholders and we look forward to a long-term partnership.”

Stock Performance

MedMen stock was lately trading at $3.95 on the OTC Markets. It has dropped from its 52-week high of $5.45 but remains above its year low of $2.61. It is trading at C$5.17 on the Canadian Securities Exchange, above the year low of C$2.61 and near the year high of C$5.45.



About Us

The Green Market Report focuses on the financial news of the rapidly growing cannabis industry. Our target approach filters out the daily noise and does a deep dive into the financial, business and economic side of the cannabis industry. Our team is cultivating the industry’s critical news into one source and providing open source insights and data analysis


READ MORE



Recent Tweets

@GreenMarketRpt – 5 hours

Executive Spotlight: Liesl Bernard, CEO of

@GreenMarketRpt – 5 hours

RT : Our Founder & CEO was featured in the Executive Spotlight! Check out the full article here;

@GreenMarketRpt – 7 hours

Our biggest fans this week: WallandBroad, cosmo_crator. Thank you! via

Back to Top

You have Successfully Subscribed!